​Ambrx (AMAM) Appoints Sonja Nelson to CFO

​Ambrx (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, today announced the appointment of Sonja Nelson to Chief Financial Officer.

“I am delighted to welcome Sonja to Ambrx as we expand our executive team, in light of our ongoing expansion,” said Feng Tian, Ph.D., Chairman of the Board, President and CEO of Ambrx. “Sonja brings a breadth of experience in financial operations, planning and strategy from within the biotechnology industry. Her arrival at Ambrx solidifies the company’s management team, and I look forward to leaning on her experience as we transition into the next stages of our company’s development.”

“I would like to thank Dr. Tian and the Ambrx team for welcoming me to the company. I’m excited to be joining Ambrx and impressed by the strength of the company’s development pipeline, and the underlying technology behind it,” said Ms. Nelson. “I look forward to leveraging my experience in the public biotech sector to help provide Ambrx with the financial optionality it needs to further its development pipeline.”

Ms. Nelson is an experienced financial executive, who joins Ambrx with 10 years of executive experience within the biotechnology industry. Most recently, she served as Chief Financial Officer at NantKwest, now ImmunityBio (NASDAQ: IBRX). Prior to NantKwest, Ms. Nelson was Vice President, Corporate Controller for AltheaDx. Previously, Ms. Nelson served as Corporate Controller at Cadence Pharmaceuticals (NASDAQ: CADX, which was acquired by Mallinckrodt plc). Ms. Nelson also served as Director, General Accounting at Cricket Communications, Inc. (acquired by AT&T) between 2008 and 2012. She started her career at KPMG and holds a bachelor’s degree in business administration with specialization in taxation and auditing from the University of Applied Sciences in Pforzheim, Germany. She is a Certified Public Accountant.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
• ADT Corp. (ADT) Names Jeff Likosar as Chief Financial Officer